Tata AIA Life Insurance has unveiled two new cancer insurance products designed to help policyholders manage not only the rising cost of treatment but also the loss of income that often follows a cancer diagnosis, reflecting growing demand for more comprehensive critical illness protection in India.
The insurer has introduced Sampoorna Care – Cancer and Sampoorna Care – Cancer Fund, two specialised plans that combine financial assistance for medical expenses with flexible income support, enabling customers to choose how they receive their insurance benefits. The launch comes as insurers increasingly adapt their offerings to meet changing consumer expectations and the financial realities of long-term illness.
Cancer remains one of India’s most pressing healthcare challenges. According to the World Health Organization’s International Agency for Research on Cancer (IARC), more than 1.57 million new cancer cases are diagnosed in the country every year. Beyond the medical impact, the disease often places considerable financial strain on patients and their families through treatment costs, reduced earning capacity and prolonged recovery periods.
Tata AIA said the new products were developed following consumer research that revealed a growing preference for regular income support over traditional lump-sum payouts. Many policyholders indicated that a steady stream of payments would help them better manage ongoing household expenses while undergoing treatment or recovering from illness.
The company’s research found that 48% of respondents preferred to receive critical illness benefits as regular income rather than a one-time payment. Among those respondents, 47% favoured monthly instalments, whilst 4% preferred annual payouts. The findings suggest that many consumers now prioritise predictable cash flow to meet recurring financial commitments during extended periods away from work.
Long-term support also emerged as a key priority. Around 76% of those surveyed said they wanted financial assistance to continue for several years after diagnosis. Of that group, 42% preferred income payments over a two-year period, whilst 34% opted for support extending over five years.
These insights have directly influenced the design of Sampoorna Care – Cancer, the flagship product among the two new offerings. The policy provides cover of up to INR50 lakh and allows customers to choose from several benefit payment options. Policyholders may receive the entire sum assured as a lump sum, opt for regular monthly income payments, or select a combination of an upfront payment followed by monthly income for up to five years.
This flexibility is intended to help families balance immediate treatment expenses with ongoing financial obligations such as mortgage repayments, education costs, household bills and other living expenses that continue even when a patient’s earning ability is affected.
The policy also includes several additional features designed to strengthen financial protection throughout the treatment journey.
One such feature is a diagnostic benefit that helps cover the costs of early-stage medical screening. Early diagnosis plays a vital role in improving treatment outcomes for many forms of cancer, yet diagnostic procedures can themselves be expensive and may discourage timely medical assessment if financial resources are limited.
Another feature is an overseas treatment booster, which offers an additional benefit equal to 10% of the sum assured for eligible treatment received abroad. The provision is designed to provide greater financial flexibility for policyholders who require specialised international medical care or choose to seek treatment outside India.
To provide long-term cost certainty, the policy also offers a 30-year premium rate guarantee. Fixed premiums over an extended period can make financial planning easier, particularly for younger customers seeking comprehensive protection without the risk of substantial premium increases later in life.
The launch reflects wider changes across India’s insurance industry, where providers are increasingly moving beyond conventional health insurance products to offer solutions that address the broader financial consequences of serious illnesses. As survival rates improve and treatment periods become longer, insurers are placing greater emphasis on replacing lost income alongside covering healthcare expenses.
The growing popularity of customisable protection plans also mirrors changing consumer attitudes. Rather than viewing critical illness insurance solely as a means of paying hospital bills, many policyholders now seek products that provide sustained financial stability throughout recovery and help protect their family’s standard of living.
By introducing Sampoorna Care – Cancer and Sampoorna Care – Cancer Fund, Tata AIA aims to deliver a more holistic approach to cancer protection. Combining flexible benefit options, diagnostic support, overseas treatment assistance and long-term premium certainty, the new plans are designed to help individuals and families navigate both the medical and financial challenges associated with a cancer diagnosis while offering greater confidence in planning for the future.